
AIDA at ESMO GI 2026 and the DiCE Masterclass in Munich
The AIDA consortium was proud to join the digestive cancer community in Munich during the 2026 edition of the ESMO Gastrointestinal Cancers Congress (ESMO GI
AIDA aims to develop and validate a multidisciplinary AI-powered assistant that will support clinicians in gastric cancer prevention by diagnosing precancerous gastric-inflammation and suggesting personalised therapeutics and monitoring.
The project is led by Tania Fleitas, a Scientific Researcher at INCLIVA. It encompasses a multidisciplinary consortium that includes some of the leading European authorities on gastric inflammation and cancer, experts in bioinformatics, artificial intelligence, and machine learning, as well as specialists in data governance and privacy. Additionally, representatives from the public administration and patient advocates are also part of the consortium.
Start
January 2023
Budget
€ 7 Mil
Duration
48 Months
12 Partners
8 Countries

The AIDA consortium was proud to join the digestive cancer community in Munich during the 2026 edition of the ESMO Gastrointestinal Cancers Congress (ESMO GI
Funded by the European Union under the Horizon Europe Framework Programme Grant Agreement Nº: 101095359. Views and opinions expressed are however those of the author(s) only and do not necessarily reflect those of the European Union or European Commission. Neither the European Union nor the European Health and Digital Executive Agency can be held responsible for them.